ID   NALM-24 R
AC   CVCL_D3ZC
DR   Wikidata; Q127382921
RX   PubMed=18599181;
CC   Population: Japanese.
CC   Selected for resistance to: UniProtKB; P50591; Human TNFSF10/CD253.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3888 ! NALM-24
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
RX   PubMed=18599181; DOI=10.1016/j.exphem.2008.04.011;
RA   Dida F., Li Y.-F., Iwao A., Deguchi T., Azuma E., Komada Y.;
RT   "Resistance to TRAIL-induced apoptosis caused by constitutional
RT   phosphorylation of Akt and PTEN in acute lymphoblastic leukemia
RT   cells.";
RL   Exp. Hematol. 36:1343-1353(2008).
//